Additionally, another research study explained the presence of protein biomarkers through their dysregulation within GDM patient samples, specifically S100 calcium binding protein A9 (S100A9) and damage associated molecular patterns, which are involved in cell cycle progression/differentiation and the innate immune response system, respectively [89]. The gene discussed is S100A9; the disease is gestational diabetes.